RA Capital Management - KALVISTA PHARMACEUTICALS INC ownership

KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 113 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
RA Capital Management ownership history of KALVISTA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$28,453,000
+11.4%
1,930,3220.0%0.62%
+38.0%
Q4 2021$25,538,000
-24.2%
1,930,3220.0%0.45%
-3.6%
Q3 2021$33,684,000
-27.2%
1,930,3220.0%0.47%
-37.1%
Q2 2021$46,251,000
+414.4%
1,930,322
+451.5%
0.74%
+445.6%
Q1 2021$8,992,000
-78.2%
350,000
-75.7%
0.14%
-92.4%
Q1 2019$41,243,000
+44.9%
1,441,0700.0%1.78%
+7.3%
Q4 2018$28,461,000
-10.7%
1,441,0700.0%1.66%
-2.7%
Q3 2018$31,862,000
+172.3%
1,441,0700.0%1.70%
+124.1%
Q2 2018$11,701,000
-14.3%
1,441,0700.0%0.76%
-27.4%
Q1 2018$13,661,000
-2.8%
1,441,0700.0%1.05%
-11.0%
Q4 2017$14,050,000
+223.0%
1,441,070
+143.8%
1.18%
+199.2%
Q3 2017$4,350,0000.0%591,0700.0%0.39%
-21.2%
Q2 2017$4,350,000
-5.8%
591,0700.0%0.50%
-11.8%
Q1 2017$4,616,000
+10.5%
591,0700.0%0.57%
-4.4%
Q4 2016$4,179,000591,0700.59%
Other shareholders
KALVISTA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,551,719$22,515,0005.42%
Prosight Management, LP 530,062$7,691,0004.12%
TANG CAPITAL MANAGEMENT LLC 1,800,000$26,118,0003.20%
Vivo Capital, LLC 1,533,559$22,252,0002.46%
Frazier Life Sciences Management, L.P. 1,572,192$22,813,0001.76%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 316,133$4,587,0001.47%
Deep Track Capital, LP 1,824,000$26,466,0001.21%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,707,100$24,770,0001.03%
DAFNA Capital Management LLC 255,313$3,705,0001.00%
COMMODORE CAPITAL LP 312,553$4,535,0000.73%
View complete list of KALVISTA PHARMACEUTICALS INC shareholders